vida: research 2026 04 29 #5772

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 08:16:35 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 08:16 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 08:16 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on specific quantitative data points like MSSP savings and GLP-1 coverage declines, and the inbox files are source metadata which are not subject to factual accuracy review in this context.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is presented uniquely.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the new data provides strong quantitative support for its strengthening, and the identified need for enrichment for the GLP-1 claim is also well-calibrated.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check for brokenness.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on specific quantitative data points like MSSP savings and GLP-1 coverage declines, and the inbox files are source metadata which are not subject to factual accuracy review in this context. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is presented uniquely. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the new data provides strong quantitative support for its strengthening, and the identified need for enrichment for the GLP-1 claim is also well-calibrated. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check for brokenness. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Session 2026-04-29 Research Journal Entry

Criterion-by-Criterion Evaluation

  1. Schema — All 11 files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal is a markdown document without frontmatter requirements, so schema compliance is satisfied for all file types present.

  2. Duplicate/redundancy — This session synthesizes multiple sources (MSSP savings, Lilly DTE, Cost Plus, GLP-1 coverage decline, MHPAEA) into a single research journal entry rather than creating separate claims, so there is no evidence injection redundancy; the entry documents a disconfirmation attempt rather than duplicating existing claims.

  3. Confidence — No standalone claims are being modified or created in this PR (only a research journal entry), so there are no confidence levels to evaluate; the journal entry documents a "FAILED disconfirmation" which strengthens Belief 3 but does not itself require a confidence rating.

  4. Wiki links — The journal entry references "Session 30's payer mandate acceleration story" and mentions Sessions 25-31 without wiki links, but these are internal journal cross-references rather than broken claim links, so no wiki link issues are present.

  5. Source quality — The 11 sources cited span CMS official data (MSSP PY2024 results), industry newsletters (9amHealth, HCPlan), and trade publications, which are appropriate primary and secondary sources for healthcare policy and market analysis claims.

  6. Specificity — The journal entry makes falsifiable claims (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings", "Employer covered lives for GLP-1 declined from 3.6M to 2.8M") with specific quantitative assertions that could be verified or contradicted.

Additional Observations

The research journal entry follows the established pattern of documenting disconfirmation attempts with specific quantitative evidence. The MSSP quality-cost co-improvement finding (depression screening up 9pp, BP control up 3pp alongside $2.48B savings) provides concrete evidence for the "prevention flywheel" mechanism. The GLP-1 coverage crisis finding (3.6M → 2.8M covered lives) adds important nuance to existing claims about GLP-1 cost pressure by documenting coverage withdrawal rather than just cost growth.

The MHPAEA mechanism statement ("payers actively raise reimbursement for medical/surgical provider networks when gaps are found, but deliberately DON'T apply the same methodology to mental health networks") is the most precise articulation I've seen in the KB of why enforcement fails structurally.

No factual discrepancies detected between the journal entry's claims and the source material patterns evident in the filenames and context.

# PR Review: Session 2026-04-29 Research Journal Entry ## Criterion-by-Criterion Evaluation 1. **Schema** — All 11 files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal is a markdown document without frontmatter requirements, so schema compliance is satisfied for all file types present. 2. **Duplicate/redundancy** — This session synthesizes multiple sources (MSSP savings, Lilly DTE, Cost Plus, GLP-1 coverage decline, MHPAEA) into a single research journal entry rather than creating separate claims, so there is no evidence injection redundancy; the entry documents a disconfirmation attempt rather than duplicating existing claims. 3. **Confidence** — No standalone claims are being modified or created in this PR (only a research journal entry), so there are no confidence levels to evaluate; the journal entry documents a "FAILED disconfirmation" which strengthens Belief 3 but does not itself require a confidence rating. 4. **Wiki links** — The journal entry references "Session 30's payer mandate acceleration story" and mentions Sessions 25-31 without wiki links, but these are internal journal cross-references rather than broken claim links, so no wiki link issues are present. 5. **Source quality** — The 11 sources cited span CMS official data (MSSP PY2024 results), industry newsletters (9amHealth, HCPlan), and trade publications, which are appropriate primary and secondary sources for healthcare policy and market analysis claims. 6. **Specificity** — The journal entry makes falsifiable claims (e.g., "full capitation DOUBLED from 7% to 14%", "MSSP 2024: Record $2.48B net savings", "Employer covered lives for GLP-1 declined from 3.6M to 2.8M") with specific quantitative assertions that could be verified or contradicted. ## Additional Observations The research journal entry follows the established pattern of documenting disconfirmation attempts with specific quantitative evidence. The MSSP quality-cost co-improvement finding (depression screening up 9pp, BP control up 3pp alongside $2.48B savings) provides concrete evidence for the "prevention flywheel" mechanism. The GLP-1 coverage crisis finding (3.6M → 2.8M covered lives) adds important nuance to existing claims about GLP-1 cost pressure by documenting coverage withdrawal rather than just cost growth. The MHPAEA mechanism statement ("payers actively raise reimbursement for medical/surgical provider networks when gaps are found, but deliberately DON'T apply the same methodology to mental health networks") is the most precise articulation I've seen in the KB of why enforcement fails structurally. No factual discrepancies detected between the journal entry's claims and the source material patterns evident in the filenames and context. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 08:19:03 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 08:19:03 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 08:21:45 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.